These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25537234)

  • 21. Strategies to increase the sensitivity of pharmacovigilance in Portugal.
    Ribeiro-Vaz I; Herdeiro MT; Polónia J; Figueiras A
    Rev Saude Publica; 2011 Feb; 45(1):129-35. PubMed ID: 21085884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Educational interventions in pharmacovigilance to improve the knowledge, attitude and the report of adverse drug reactions in healthcare professionals: Systematic Review and Meta-analysis.
    Cervantes-Arellano MJ; Castelán-Martínez OD; Marín-Campos Y; Chávez-Pacheco JL; Morales-Ríos O; Ubaldo-Reyes LM
    Daru; 2024 Jun; 32(1):421-434. PubMed ID: 38427161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals.
    Rehan HS; Chopra D; Holani SN; Mishra R
    Int J Risk Saf Med; 2014; 26(1):1-8. PubMed ID: 24796346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study.
    González-Rubio F; Calderón-Larrañaga A; Poblador-Plou B; Navarro-Pemán C; López-Cabañas A; Prados-Torres A
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1287-94. PubMed ID: 21702073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region).
    Biagi C; Montanaro N; Buccellato E; Roberto G; Vaccheri A; Motola D
    Eur J Clin Pharmacol; 2013 Feb; 69(2):237-44. PubMed ID: 22706618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system.
    Alvarez-Requejo A; Carvajal A; Bégaud B; Moride Y; Vega T; Arias LH
    Eur J Clin Pharmacol; 1998 Aug; 54(6):483-8. PubMed ID: 9776440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicians' knowledge and attitude towards adverse event reporting system and result to intervention--randomized nested trial among Bulgarian physicians.
    Stoynova V; Getov IN; Naseva EK; Lebanova HV; Grigorov EE
    Med Glas (Zenica); 2013 Aug; 10(2):365-72. PubMed ID: 23892860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals.
    Pérez García M; Figueras A
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1295-302. PubMed ID: 21793098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse drug reaction reporting in institutions across six Chinese provinces: a cross-sectional study.
    Zhang X; Niu R; Feng B; Guo J; Liu Y; Liu X
    Expert Opin Drug Saf; 2019 Jan; 18(1):59-68. PubMed ID: 29883236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis.
    Ribeiro-Vaz I; Silva AM; Costa Santos C; Cruz-Correia R
    BMC Med Inform Decis Mak; 2016 Mar; 16():27. PubMed ID: 26926375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.
    Vallano A; Cereza G; Pedròs C; Agustí A; Danés I; Aguilera C; Arnau JM
    Br J Clin Pharmacol; 2005 Dec; 60(6):653-8. PubMed ID: 16305591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods.
    Gerritsen R; Faddegon H; Dijkers F; van Grootheest K; van Puijenbroek E
    Drug Saf; 2011 Sep; 34(9):755-62. PubMed ID: 21830837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
    Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
    Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of online reporting systems and their compatibility check with respective adverse drug reaction reporting forms.
    Maharshi V; Nagar P
    Indian J Pharmacol; 2017; 49(5):374-382. PubMed ID: 29515278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine.
    Tabali M; Jeschke E; Bockelbrink A; Witt CM; Willich SN; Ostermann T; Matthes H
    BMC Public Health; 2009 Jul; 9():274. PubMed ID: 19643033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of a peer support intervention to promote the detection, reporting and management of adverse drug reactions in people living with HIV in Uganda: a protocol for a quasi-experimental study.
    Kiguba R; Ndagije HB; Nambasa V; Katureebe C; Zakumumpa H; Nanyonga SM; Ssanyu JN; Tregunno P; Harrison K; Merle CS; Raguenaud ME; Kitutu FE
    BMJ Open; 2022 May; 12(5):e056039. PubMed ID: 35589351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interventions to improve adverse drug reaction reporting: A scoping review.
    Khalili M; Mesgarpour B; Sharifi H; Daneshvar Dehnavi S; Haghdoost AA
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):965-992. PubMed ID: 32431069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.